All In MedTech

Device Trial Radar · NCT01259271

Selective Nerve Stimulation (SNS) Pilot Study

Single Center, Single Blind, Randomized, Sham Controlled Pilot Study Using Selective Nerve Stimulation (SNS) Signal for Nerve Modulation With Three Amplitudes (Supra-threshold, Sub-threshold and Sham)

Last checked: Nov 19, 2026Latest source record: Oct 18, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

60

Actual

Start

Nov 1, 2010

Primary completion

Feb 1, 2011

Study completion Feb 1, 2011

Sponsor

Lead sponsor
Codman & ShurtleffNot on our public-company list
Sponsor type
Industry
First posted
Dec 14, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Randomized
Model
Crossover
Masking
Single (participant)
Primary purpose
Other
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to examine if a new device, the SNS (Selective Nerve Stimulator), is effective in changing the way nerves work as pain killing drugs sometimes do. During this study, the study team will place 2 adhesive patches on the inside of one of the wrists of the non-dominant hand (if the subject is right-handed the electrodes will be placed on the subject's left wrist) of the study subject. These patches will be connected by wires (leads) to a small box with a headphone jack. This is designed to provide gentle electrical stimulation through the skin. This study will look at the amount of change from normal nerve function, the sensory effects (feeling, sensations in the body), and any changes the subject has when performing the 2 hour tests. The safety of the study device will also be evaluated.

Conditions

  • Healthy
  • Pain

Interventions

  • Selective Nerve Stimulation (SNS) stimulator deviceDevice

    Two hours per study visit separated by a minimum of a 20 hour wash out period between stimulations.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Modulation of Median Nerve Perception or Nerve PhysiologyTime frame: > 2 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Codman & Shurtleff

    Raynham, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.